Transient receptor potential channel subfamily M member 5 (TRPM5) is an important downstream signaling component in a subset of taste receptor cells making it a potential target for taste modulation. Interestingly, TRPM5 has been detected in extra-oral tissues; however, the function of extra-gustatory TRPM5-expressing cells is less well understood. To facilitate visualization and manipulation of TRPM5-expressing cells in mice, we generated a Cre knock-in TRPM5 allele by homologous recombination. We then used the novel TRPM5-IRES-Cre mouse strain to report TRPM5 expression by activating a τGFP transgene. To confirm faithful coexpression of τGFP and TRPM5 we generated and validated a new anti-TRPM5 antiserum enabling us to analyze acute TRPM5 protein expression. τGFP cells were found in taste bud cells of the vallate, foliate, and fungiform papillae as well as in the palate. We also detected TRPM5 expression in several other tissues such as in the septal organ of Masera. Interestingly, in the olfactory epithelium of adult mice acute TRPM5 expression was detected in only one (short microvillar cells) of two cell populations previously reported to express TRPM5. The TRPM5-IC mouse strain described here represents a novel genetic tool and will facilitate the study and tissue-specific manipulation of TRPM5-expressing cells in vivo.
Introduction
The transient receptor potential cation channel subfamily M member 5 (TRPM5) is a Ca 2+ -activated monovalent cation channel modulated by voltage, heat, and phosphatidylinositol 4,5-bisphosphate (PIP2) (Liman 2014 ). An initial study of TRPM5 mRNA expression in different tissues by northern blot reported high expression levels in the liver and low-level expression in the heart, brain, kidney, and testis (Enklaar et al. 2000) . Subsequent analyses using a probe located in a different region of the gene showed that TPM5 mRNA is highly expressed in taste tissue with lower expression levels in the stomach and small intestine (Perez et al. 2002) . Ensuing in situ hybridization experiments confirmed TRPM5 expression in type II taste receptor cells of mouse vallate and foliate papillae where it functions as an important downstream signaling component for sweet, bitter, and umami detection (Zhang et al. 2003) .
The generation of a transgenic mouse strain expressing enhanced green fluorescent protein (EGFP) under the control of a fragment of the TRPM5 promoter ) represented a major advancement in mapping sites of TRPM5 expression throughout the body. While TRPM5 expression in type II taste receptor cells was confirmed (Clapp et al. 2006) , TRPM5 expressing cells were also found in the olfactory epithelium (OE), vomeronasal organ (VNO), gastrointestinal tract, and respiratory epithelium (Kaske et al. 2007 ). In the OE, EGFP expression was detected in at least two morphologically distinct populations of cells-microvillar-like cells located in the apical part of the OE and olfactory sensory neurons (OSNs) possessing axon-like processes targeted to the olfactory bulb (Hansen and Finger 2008) . In the stomach, TRPM5 is expressed in brush cells and is coexpressed with villin and cytokeratin 18 (Kaske et al. 2007; Bezencon et al. 2008) . TRPM5 expression was also detected in various parts of the mouse intestinal tract where it is coexpressed with different taste signaling molecules (Bezencon et al. 2008) , β-endorphin, and Met-enkephalin (Kokrashvili et al. 2009 ). In the mouse respiratory epithelium, EGFP expression was reported in a large population of solitary chemosensory cells immunopositive for the vesicle-associated membrane protein synaptobrevin-2 and responsive to odorous irritants (Lin et al. 2008b) . TRPM5 is also expressed in insulin secreting β-cells of the pancreatic islets, where it is thought to regulate glucose-stimulated insulin secretion (Prawitt et al. 2003; Brixel et al. 2010; Colsoul et al. 2010) .
Together these studies have contributed important insights into the physiological role of TRPM5 in various tissues making it a target for taste improvement (Sprous and Palmer 2010) , the therapeutic treatment of type 2 diabetes (Brixel et al. 2010) as well as obesity (Palmer and Lunn 2013) . To be able to manipulate TRPM5-expressing cells in vivo, we used gene targeting to generate a mutant TRPM5 allele. Here we report the generation of a TRPM5-specific Cre knock-in mouse strain and the characterization of TRPM5-expressing cells in these mice using a binary genetic strategy.
Materials and methods

Construction of the TRPM5-IRES-Cre (TRPM5-IC) targeting vector
All fragments used for the generation of the TRPM5-IC targeting construct were subcloned into the pKO-V901-DTA (diphtheria toxin A) plasmid containing a phosphoglycerate kinase (pgk) promoter-driven DTA cassette (Wen et al. 2008) . The final targeting construct includes a 5′ TRPM5 homology arm, an internal ribosomal entry site (IRES)-Cre-pgk promoter-driven Flp recombination target (FRT)-neomycin (neo)-FRT cassette (Eggan et al. 2004 ) and a 3′ TRPM5 homology arm. To generate the 5′ homology arm, a 3506-bp fragment including exon 25 of the TRPM5 gene was amplified by polymerase chain reaction (PCR) from genomic R1 mouse embryonic stem (ES) cell DNA. A XhoI restriction site 5′ to the homology arm and an AscI restriction site just 3′ of the stop codon of the TRPM5 gene were introduced by PCR-based mutagenesis, and the fragment was then subcloned into the multiple cloning site of the pKO V901-DTA plasmid. Next, a 4.0 kb 3′ homology arm including 5′ AscI and 3′ SalI restriction sites was PCR-amplified and inserted into pKO-V901-DTA. To minimize PCRintroduced mutations, high fidelity pfu DNA polymerase was used for all PCR amplification steps. Finally an IRES-Cre-pgk promoter-driven FRT-neo-FRT cassette (Eggan et al. 2004 ) was inserted into the AscI site resulting in the pKO-TRPM5-IRES-Cre-FRT-neo-FRT targeting vector. The integrity of the final targeting construct was verified by restriction mapping and nucleotide sequencing (Applied Biosystems, Sequence Scanner v1.0) of selected regions.
Gene targeting
The final targeting construct was linearized with NotI and electroporated into R1 ES cells (Nagy et al. 1993 ) by the Transgenic Service Unit at the Center for Molecular Neurobiology Hamburg (ZMNH). Correctly targeted ES cells were identifed by Southern blot analysis and then used to generate TRPM5-IC mice following standard protocols [injection of ES cells (129/Sv) into blastocysts (C57BL/6), implantation of injected blastocysts into (C57BL/6xCBA) F1 foster mothers, backcross of male chimeras with C57BL/6 females]. In order to remove the neomycin cassette, the F1 TRPM5-IC animals were crossed with a transgenic mouse strain in which regulatory sequences of the human β-actin (ACTB) gene drive ubiquitous FLP recombinase (FLPe) expression (Dymecki 1996) .
Mice
Mice were kept under a standard light/dark cycle with food and water ad libitum. All experiments were approved by, and conducted in accordance with the guidelines of, the Animal Welfare Committee of the Universities of Hamburg and the Saarland. Heterozygous TRPM5-IC neo-animals were interbred to obtain animals homozygous for the recombinant TRPM5 allele. TRPM5-IC mice are viable, fertile, and produce litters comparable to those of wild-type mice. To monitor Cre recombinase activity, TRPM5-IC mice were bred with a fluorescent ROSA26 reporter mouse strain (eR26-τGFP) (Wen et al. 2011 ) to generate TRPM5-IC/eR26-τGFP double knock-in mice. All mice analyzed in this study were heterozygous for both the TRPM5-IC and eROSA26 knock-in allele.
Genotyping
For genotyping, genomic DNA from mouse tail biopsies was isolated by proteinase K (Roth) digestion and isopropanol alcohol extraction and subjected to PCR amplification. To genotype TRPM5-IC mice we used primers TRPM5-IC_for 5′-CGGATACACTGGCTCCAGGAGGCAC-3′ and TRPM5-IC_rev1 5′-CGGAATTCATCGATGATATCAGATCCGG-3′ to amplify a 460-bp knock-in amplicon or TRPM5-IC_for 5′-CGGATACA CTGGCTCCAGGAGGCAC-3′ and TRPM5-IC_rev2 5′-GTCCT GCCCTCTAGGAGCTGGTCAGC-3′ to amplify an 836-bp fragment of the TRPM5 wild-type allele. To confirm the presence of the FLPe transgene in TRPM5-IC knock-in mice we used primers FLPe_ for 5′-GTCACTGCAGTTTAAATACAAGACG-3′ and FLPe_rev 5′-GTTGCGCTAAAGAAGTATATGTGCC-3′ to amplify part of the FLPe sequence (480 bp). To identify the ROSA knock-in allele we used primers ROSA_for 5′-CGAAGTCGCTCTGAGTTGTTATC-3′ and ROSA-rev1 5′-GCAGATGGAGCGGGAGAAAT-3′ (400 bp). The ROSA wild-type allele was amplified using ROSA_for 5′-CGAAGTCGCTCTGAGTTGTTATC-3′ and ROSA_rev2 5′-GTCCCTATTGGCGTTACTATG-3′ primers (600 bp). PCR products were analyzed by electrophoresis using 1% agarose gels (Sigma).
Isolation of lingual and palatal epithelia
Lingual and palatal epithelia were isolated as described previously (Voigt et al. 2012) . Briefly, mice were anesthetized using isoflurane and sacrificed by cervical dislocation. Subsequently, the tongue or palate was removed and an enzyme mix containing 2.5 mg/mL dispase II (neutral protease, grade II; Roche), 1 mg/mL collagenase A (Roche), 2.5 mg/mL trypsin inhibitor (Type I-S from Soybean; Sigma Aldrich) and 0.5 mg/mL DNase I (Roche) was injected directly under the epithelial layer. Injected tissue was incubated for 20 min (tongue) or 10 min (palate) in Ca 2+ /Mg 2+ free Tyrode's solution with aeration. The epithelia were peeled, fixed in a sylgard dish, and incubated in 4% ice-cold paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 10 min. Finally, the fixed tissue was transferred onto Superfrost Plus slides (Menzel) and mounted using fluorescent mounting medium (Dako). Images from whole lingual and palatal epithelia were obtained using a MIRAX MIDI Scan System (Zeiss). Photographic images were processed using Adobe Photoshop 7.0.1 software (Adobe Systems).
Tissue preparation
Eight-to twenty-week-old mice were anesthetized with ketamine/ xylazine (Bayer) anesthesia and perfused transcardially with 10 mL PBS at 37 °C, followed by 100 mL ice-cold 4% PFA in PBS. Organs were removed and soaked in PFA at 4 °C for 2 h. For cryostat sectioning, organs were transferred to 30% sucrose in PBS until the organs sank to the bottom, and then frozen in tissue-freezing O.C.T. compound (Leica Microsystems GmbH). Nose tissue was prepared as reported before (Ishii et al. 2004 ). Serial 10-or 14-µm-thick sections were generated with a cryostat (CM3050; Leica) and were collected on SuperFrost Plus glass slides (Roth) to be used for in situ hybridization or immunofluorescence (IF) analysis.
Generation of probes for in situ hybridization
The mouse TRPM5 cDNA sequence corresponding to 19-3495 bp subcloned into the pBluscript II SK − vector (Stratagene) was a gift from Dr Hiroaki Matsunami (Duke University, Durham, NC, USA). To reduce the probe length to 1.1 kb, the plasmid containing the TRPM5 cDNA sequence was specifically digested with BamHI and XhoI. The 1.1-kb fragment corresponding to the 3′ TRPM5 cDNA sequence was then gel-purified using the peqGOLD Gel Extraction Kit (C-Line). The purified fragment was subcloned into pBluescript II KS + using BamHI and XhoI restriction enzymes. For Cre recombinase in situ hybridization, a 401-bp-long Cre recombinase cDNA fragment subcloned into pBluescript I KS − (Stratagene) was used as a template. To prepare sense and antisense templates for riboprobe synthesis, the plasmid was linearized with appropriate restriction enyzmes. In vitro transcriptions in the presence of digoxigeninlabeled ribonucleotides (Roche Applied Science) were performed to generate antisense and sense probes. Additionally, 50 U of RNase Inhibitor (Fermentas) was used during the transcription procedure. To remove genomic DNA, RNA samples were treated with DNase I (Invitrogen) for 30 min at 37 °C. Probes were purified by ammonium chloride/ethanol precipitation overnight at −20 °C.
Fluorescent in situ hybridization
10-μm cryosections prepared from perfused mouse tissue were postfixed with 4% PFA in PBS containing 1 mM MgCl 2 and adjusted to pH 7.2 for 5 min, rinsed with PBS, incubated in 0.2 M HCl for 10 min and in 1% Triton-X 100 for 2 min. Next, sections were treated with proteinase K (20 μg/mL) in PBS for 5 min, incubated in 0.2% glycine in PBS for 5 min, rinsed twice in PBS for 5 min, and fixed again in 4% PFA in PBS for 5 min. After washing in PBS for 5 min, sections were acetylated in 0.1 M triethanolamine, pH 8.0, by drop-wise addition of acetic anhydride to a final concentration of 0.25% for 10 min and rinsed in PBS.
Next, sections were prehybridized for 6 h at 50 °C in prehybridization solution (50% formamide, prehybridization salt solution, pH 6.8, 5× Denhardt´s reagent, 0.2% sodium dodecyl sulfate (SDS), 250 μg/mL yeast tRNA, 250 μg/mL salmon testis DNA). Hybridization buffer containing prehybridization buffer, 10% (w/v) dextran sulfate, and the riboprobe was heated for 10 min at 85 °C, applied onto tissue sections, and was incubated overnight at 50 °C in a chamber humidified with 50% formamide.
After overnight hybridization, the sections were rinsed three times in 2× saline-sodium cirate (SSC) for 5 min and treated with RNase buffer (RNase 0.83 µg/mL) at 37 °C for 15 min. Then sections were rinsed once in 0.4× SSC at room temperature (RT) for 15 min and two times in 0.4× SSC at 40 °C for 30 min. Subsequently, sections were equilibrated in TNT buffer (0.15 M NaCl, 0.1 M Tris-HCl, and 0.05 % Tween-20, pH 7.5) for 5 min at RT and blocked using TNB buffer (0.5 % TSA blocking reagent; PerkinElmer) for 1 h at RT. Sections were then incubated with anti-digoxigenin antibody coupled to horseradish peroxidase (Roche, Applied Science) 1:250 in TNB buffer for 1 h at RT. To remove an excess of unbound antibodies, sections were washed three times in TNT buffer for 5 min each. Fluorescein-tyramide (Perkin Elmer, 1:50) in amplification diluent was applied onto the slides in darkness for exactly 10 min. After three washes with TNT buffer for 5 min each, the sections were changed to PBS-T (0.05%) and washed three times. Next, the sections were blocked using TNB buffer for 30 min at RT and incubated with a rabbit anti-GFP antiserum (1:500, catalog # A11122, Invitrogen) in TNB buffer for 2 h at RT or overnight at 4 °C. The sections were briefly rinsed with PBS and washed three times (5 min each) in PBS-T (0.1%). After washing, the sections were incubated with a donkey anti-rabbit Alexa Fluor 647 antiserum (1:300, catalog # A31573, Molecular Probes) for 2 h at RT. Slides were washed three times for 5 min using PBS-T before coverslipping them with fluorescent mounting medium (Dako). Images were taken with a confocal laser scanning microscopy (TCS SP2, Leica). The sections were sequentially scanned at the excitation wavelengths 488 nm (fluorescin) and 633 nm (Alexa Fluor 647), respectively. Emission of the fluorophores was detected between 500 and 530 nm (fluorescin) and 650 and 740 nm (Alexa Fluor 647), respectively.
Generation and affinity purification of the anti-TRPM5 antiserum
A peptide corresponding to the C-terminal 23 amino acid residues of mouse TRPM5 (RefSeq NP_064673.2) was synthesized in-house, coupled to keyhole limpet hemocyanine and used to immunize two rabbits (794 and 1050). The sera were affinity purified using the synthetic peptide coupled to epoxy-activated Sepharose (Amersham Pharmacia Biotech) and tested by western blot analysis. Antibody 1050 displayed the highest sensitivity to TRPM5 and was subsequently used for immunohistochemistry.
Immunohistochemistry
Mouse tissue sections (14 µm) were washed in PBS and then heated in Tris-buffer (pH 9) for 10 min (AADC) or 30 min (Skn-1a) at 80 °C. Sections for NTPDase2 staining were not heated. Subsequently sections were washed again twice in PBS and then incubated in PBS containing 0.05% Triton-X 100 for 10 min (20 min for the NTPDase2 staining), rinsed three times in TNT buffer for 5 min, and then blocked in TNB buffer for 30 min at RT. Sections were then treated either with rabbit anti-Skn-1a (Pou2f3) (1:300; catalog # sc-330, Santa Cruz Biotechnology), rabbit anti-NTPDase2 [1:1000, (Bartel et al. 2006 )] or rabbit anti-AADC (1:500; catalog # GTX30448, GeneTex) antisera, all diluted in TNB buffer, incubated at RT for 2 h and followed by 4 °C incubation overnight. On the next day, the slides were washed three times for 10 min in TNT and then treated with donkey anti-rabbit IgG Alexa Fluor 647 (1:300, catalog # A-31573, Invitrogen) in TNB for 1 h at RT. Slides were washed three times for 5 min using TNT before coverslipping them with fluorescent mounting medium (Dako). Fluorescent images were collected using a confocal laser scanning microscope (TCS SP2, Leica). Sequential 0.5-μm scanning steps were used to image the entire depth of the tissue with the excitation wavelengths 488, 561, and 633 nm respectively. Emission of the fluorochromes and fluorescent proteins were detected between 505 and 530 nm (488 nm excitation), 590 and 630 nm (τGFP), or 645 and 740 nm (Alexa Fluor 647). For immunohistochemistry of the olfactory marker protein OMP, sections were incubated in blocking reagent (0.3% Triton X-100, 4% normal horse serum in PBS) for 1 h at RT, followed by anti-OMP antiserum (1:4000 in blocking reagent, goat polyclonal #544-10001, WAKO Chemicals) overnight at 4 °C. After three rinses in PBS, sections were incubated for 1 h in Alexa Fluor 555 conjugated donkey-anti-goat secondary antiserum in PBS (1:1000, Invitrogen), rinsed in PBS and mounted in DAKO fluorescence mounting medium.
To perform TRPM5 immunohistochemistry, 14-μm sections were pretreated as described above and then incubated with a mixture of rabbit anti-TRPM5 (1:250-1:5000) and chicken anti-GFP (1:1000, catalog # A10262, Invitrogen) antisera diluted in TNB overnight at 4 °C. On the following day, the slides were washed three times in TNT buffer and incubated with donkey anti-rabbit Cy3 Fab fragment (1:500, catalog # 711-167-003, Jackson Dianova) diluted in TNB for 2 h at RT. After washing in TNT three times, the slides were either treated with goat anti-chicken Alexa 488 (1:500, catalog # A11039, Life Technologies) for 2 h at RT or with biotinylated anti-chicken antiserum (1:1000, catalog # BA-9010, Vector Labs) for 1 h at RT. After three washes with TNT buffer, the biotinylated chicken antibodytreated slides were incubated with streptavidin Alexa 488 (1:500, catalog # S-32354, Invitrogen) diluted in TNB for 30 min at RT. Slides were then nuclear-stained in bis-benzimide solution for 10 min at RT, washed three times with PBS, coverslipped with fluoromount medium and used for microscopic imaging. Fluorescent images were collected using a confocal laser scanning microscope (Leica TCS SP2, Zeiss 710/ Zeiss 780) or an epifluorescence microscope (Zeiss Axioskop).
Quantifications
Images from 10 (in situ) or 14 (IF) μm serial sections were collected using confocal laser scanning microscopes (Leica TCS SP2/Zeiss 710/Zeiss 780). Scanning steps of 0.5 (in situ) or 1 (IF) μm were used to sequentially scan the entire depth of the section (z-stack). The scanned images were used for quantification of the τGFP and TRPM5/Cre signal through the entire z-stack using Image-J or Leica light software.
Results
Generation of the TRPM5-IRES-Cre (TRPM5-IC) mouse strain
The linearized targeting construct containing an IRES-Cre cassette ( Figure 1A ) was electroporated into R1 ES cells and 216 neomycinresistant ES cell clones were picked and analyzed by Southern blot using an external 5′ probe ( Figure 1B) . In total, 26 positively targeted ES cell clones were detected corresponding to a targeting frequency of 8.3%. Southern blot analysis using an external 3′ probe confirmed homologous recombination at the TRPM5 locus ( Figure 1C ). Two targeted ES clones were expanded and injected into C57BL/6J blastocysts to generate the TRPM5-IRES-Cre neo+ mouse strain. After backcrossing the chimeric animals with C57BL/6J wild-type animals to ensure germline transmission, the F1 animals were bred to a transgenic FLPe deleter mouse strain to remove the neomycin resistance cassette from the TRPM5 knock-in allele. Animals carrying both the TRPM5 knock-in allele and the FLPe transgene were identified by PCR genotyping using primers specific for the TRPM5 and FLPe gene sequences ( Figure 1D,E) . Southern blot analysis of DNA from FLPe and TRPM5 Cre knock-in double positive animals confirmed successful removal of the neomycin cassette in the TRPM5-IRESCre neo-(TRPM5-IC) knock-in animals ( Figure 1F) . One of the two ES cell-derived TRPM5-IC mouse lines was used for all further experiments.
τGFP is expressed in all lingual papillae in TRPM5-IC/eR26-τGFP mice
To monitor Cre recombinase activity, TRPM5-IC mice were bred with a fluorescent reporter mouse strain (Wen et al. 2011) . In TRPM5-IC/ eR26-τGFP double knock-in mice, the mutant TRPM5 allele is transcribed into a bicistronic messenger RNA from which TRPM5 and Cre recombinase are independently translated (Figure 2-C ). Cremediated recombination then removes the transcriptional stop signal from the eR26-τGFP allele leading to constitutive τGFP expression in these cells. Because Cre-mediated recombination is irreversible, τGFP expression in TRPM5-IC/eR26-τGFP mice reports the history of activity of the TRPM5 promoter. Therefore τGFP labels both cells that used to express TRPM5 as well as cells that acutely express TRPM5 at the time of analysis in these animals.
To analyze Cre-mediated τGFP expression in TRPM5-IC/eR26-τGFP mice, we first prepared whole mount tongue epithelium from these animals (n = 3). Systematic analysis of the entire epithelium revealed τGFP expression in all papilla types of the tongue ( Figure 2D ). Large numbers of τGFP cells were found in the foliate (FoP-lateral region, Figure 2E ), in the vallate (VP-posterior center region, Figure 2F ) and in the fungiform (FuP-anterior region, Figure 2G ) papillae. In addition, τGFP cells were also detected in whole mount epithelium prepared from the palate ( Figure 2H ), more specifically in the Geschmacksstreifen (GS, Figure 2I ) and in the soft palate (SP, Figure 2J ). This result is consistent with previous RT-PCR studies showing TRPM5 expression in different papillae of the tongue (Perez et al. 2002) .
τGFP cells express TRPM5/Cre mRNA in the vallate papillae
To analyze whether the τGFP cells in the taste papillae acutely express TRPM5/Cre mRNA in TRPM5-IC/eR26-τGFP animals, we used a combination of in situ hybridization and IF analysis. VP cryosections (10 μm) from perfused TRPM5-IC/eR26-τGFP animals were first hybridized with a digoxigenin-labeled TRPM5 or Cre recombinase riboprobe and subsequently stained with an antiserum against GFP. Double labeling experiments showed that both TRPM5 and Cre mRNA are specifically expressed in the τGFP cells in the VP of the tongue in TRPM5-IC/eR26-τGFP animals (Figure 3 ). Control experiments with TRPM5-IC/eR26-τGFP and wild-type animals confirmed the specificity of both riboprobes and antisera used.
To determine the percentage of co-localization between TRPM5 mRNA/Cre mRNA positive cells and τGFP cells, in situ hybridization/immunohistochemistry was performed on VP sections and used for quantitative analysis. Of 195 cells analyzed in 47 taste buds of two mice, all were double positive for TRPM5 mRNA and GFP IF (Table 1) . Cre in situ hybridization and GFP immunohistochemisty quantification analysis detected 292 cells in 73 taste buds of the two mice and showed 100% co-localization between Cre mRNA and τGFP cells (Table 1) . These results confirm that τGFP faithfully reports acute TRPM5 mRNA expression in these cells.
τGFP faithfully reports TRPM5 protein expression in cells of the vallate papillae
To be able to detect TRPM5 protein in tissue sections, we generated a polyclonal anti-TRPM5 antiserum against the C-terminal part of the protein using a peptide corresponding to amino acids 1138-1158 of the TRPM5 protein as the antigen. To test the specificity of the anti-TRPM5 antiserum we used VP sections from TRPM5 knock-out (TRPM5 KO) mice (kindly provided by Rudi Vennekens, Katholieke Universiteit Leuven). Homozygous TRPM5 KO animals lack exons 15-19 of the TRPM5 gene, which code for the first five transmembrane domains and the pore region of the channel, resulting in a nonfunctional TRPM5 protein (Zhang et al. 2003) . VP sections from TRPM5 KO mice (n = 2) stained with the anti-TRPM5 antiserum did not show any immunolabeling ( Figure 4A ), whereas staining against the type II cell marker PLCβ2 demonstrated specific immunolabeling in the VP ( Figure 4B ). In contrast, control experiments on wild-type VP sections clearly detected the TRPM5 signal ( Figure 4C ). These data demonstrate that the new anti-TRPM5 antiserum is specific and detects endogenous TRPM5 protein in mouse taste tissue.
We next stained 14-μm cryosections from different papillae of a TRPM5-IC/eR26-τGFP animal with both antisera against TRPM5 and GFP. Both TRPM5 and τGFP expression was detected in all three tongue papillae (VP, FoP, and FuP; Figure 4D-4F) . We then quantified TRPM5 and τGFP expression on double-labeled VP sections with single-cell resolution using a confocal laser scanning microscope (z-stack, 1-μm scanning steps). In total, we analyzed 293 taste buds containing 1767 τGFP-positive cells from three independent animals (Table 2) . We found that all τGFP cells analyzed acutely express TRPM5 protein, demonstrating the validity of our binary genetic approach.
τGFP/TRPM5 cells are type II taste bud cells
To further characterize the τGFP cell population in TRPM5-IC/ eR26-τGFP mice, we stained VP sections prepared from these 
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Chemical Senses, 2015, Vol. 40, No. 6 animals with antisera against different taste cell markers. IF analysis using antisera against the type I cell marker nucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) and the type III cell marker aromatic amino acid decarboxylase (AADC) did not label the τGFP cells ( Figure 5A,C) . Instead, all τGFP cells were labeled with an antiserum against the type II taste cell marker Skn-1a (Matsumoto et al. 2011) , confirming that the τGFP/TRPM5 cells are type II taste cells ( Figure 5B ).
τGFP/TRPM5 expression in extra-gustatory tissues
Next we analyzed τGFP and TRPM5 expression in extra-gustatory tissues in TRPM5-IC/eR26-τGFP mice.
τGFP/TRPM5 is expressed in chemosensory cells of the gastric groove
To study τGFP expression in cells lining the gastric groove, 14-μm sections through the TRPM5-IC/eR26-τGFP mouse stomach were used for the analysis. We detected a cluster of long and elongated τGFP cells parallel to the limiting ridge region of the mouse stomach ( Figure 6A,B) . To confirm that the expression of τGFP indicates acute TRPM5 expression in the labeled cells, sections through the gastric mucosa prepared from TRPM5-IC/eR26-τGFP animals were double-stained with antisera against TRPM5 and GFP. Double labeling showed that most of the τGFP cells are labeled by the TRPM5 antiserum (Figure 6,B) . Additional τGFP+ cells not labeled by the TRPM5 antiserum likely reflect the history of activity of the TRPM5 promoter in this tissue. This result confirms TRPM5 expression in a subset of cells in the gastric groove, raising the possibility that it is involved in chemodetection in the murine stomach (Bezencon et al. 2007; Eberle et al. 2013a Eberle et al. , 2013b Eberle et al. , 2014 .
τGFP/TRPM5 is expressed in the mouse intestinal tract Next, sections from the intestinal tract (duodenum and colon) prepared from TRPM5-IC/eR26-τGFP mice were analyzed for τGFP expression. Consistent with previous studies (Bezencon et al. 2007 ), τGFP cells were detected in the duodenal villi, duodenal gland, Figure 3 . ISH/IHC analysis of vallate papillae sections of TRPM5-IC/eR26-τGFP mice; 10-μm vallate papillae (VP) sections were hybridized either with digoxigeninlabeled TRPM5-or Cre-specific riboprobes as indicated, and subsequently immunostained using an anti-GFP antiserum (A and C). Note the complete overlap between τGFP and TRPM5 mRNA/Cre mRNA-expressing cells. No TRPM5 signal was detected using the sense probe in TRPM5-IC/eR26-τGFP mouse VP (B) and wild-type mice did not show show any labeling using the anti-GFP antiserum (D). Note that a similarly spotted ISH signal has been reported before for TRPM5 (Moyer et al. 2009 ). Scale bars 50 µm. as, antisense; s, sense probe. and also in the colon. In the intestine, τGFP cells were distributed throughout the epithelium lining the villi and glands. The τGFP cells within the epithelium were pear-shaped suggesting that they may be tufted cells, a solitary population of epithelial cells in the mouse intestinal tract. To examine whether the τGFP expression reflects acute endogenous TRPM5 expression in these cells, sections from different intestinal parts were immunostained using the anti-TRPM5 and anti-GFP antisera. These double-labeling experiments showed that the τGFP cells are mostly co-localized with TRPM5 antiserum both in the mouse duodenum and colon demonstrating faithful activation of τGFP in TRPM5-expressing cells ( Figure 6C,D) . In addition to the gastointestinal tract, τGFP cells were detected in several other tissues such as the linings of trachea and bronchus (Tizzano et al. 2011 ) and also in the urethra (Deckmann et al. 2014 ). TRPM5 and GFP double labeling confirmed that most of these cells indeed express TRPM5 at the stage analyzed (Figure 7) . τGFP/TRPM5 is expressed in microvillar cells in the main olfactory epithelium Another important chemosensory system is the olfactory system, which mediates the detection of a wide variety of odorants and pheromonal cues. To analyze τGFP expression in the olfactory system, nose sections were prepared from adult TRPM5-IC/eR26-τGFP animals. In the main OE, τGFP was detected in at least two morphologically distinct cell types ( Figure 8A,B) . One population is short in size and is localized at the apical part of the mouse OE. These cells are sparsely distributed throughout the epithelium and likely correspond to microvillar cells. The second cell type is represented by a subpopulation of OSNs, with somata located at different depths of the OE, extending apical dendrites and long axons reaching to the basal lamina. In addition to the typical morphology, at least some τGFP + OSNs in the apical OE show immunoreactivity for the olfactory marker protein OMP, a maturity marker ( Figure 8C) ; immature τGFP + OSNs in the basal OE co-localize with Gap43 (not shown). Moreover, axonal processes form τGFP + bundles projecting to the olfactory bulb, where they terminate in regions of glomerular neuropil ( Figure 8D ). Interestingly, double-immunolabeling studies using antisera against TRPM5 and GFP revealed that TRPM5 is faithfully expressed in the short population of cells, whereas co-localization between GFP and TRPM5 in the sensory neurons was absent ( Figure 8B ). In the VNO, GFP was present in a subpopulation of vomeronasal sensory neurons, but not in microvillar cells. Instead, sparsely distributed cells at the non-sensory site of the VNO showed GFP expression ( Figure 8E ). In the septal organ of Masera (SOM), a distinct olfactory subsystem, GFP was detected in a subpopulation of OSNs as well as in microvillar cells ( Figure 8F ). In contrast, GFP fluorescence was virtually absent in neurons of the Grueneberg Ganglion (not shown).
Discussion
The present study made use of a novel genetic approach to label TRPM5-expressing cells in vivo. Using gene targeting in ES cells, we have generated a modified TRPM5 allele to coexpress Cre recombinase with the TRPM5 gene. We then used a binary genetic strategy to characterize this new TRPM5 Cre driver mouse strain. In this experimental paradigm, TRPM5 promoter-driven Cre expression activates a τGFP reporter transgene in TRPM5-IC/eR26-τGFP mice. A conventional transgenic approach is often chosen over a knock-in approach for genetic labeling because pronucleus injection is significantly faster and less labor intense than homologous recombination in ES cells. However it is well documented that expressing a reporter such as GFP under control of a short promoter fragment comes with a number of potential limitations. Numerous studies reported abberant transgene expression due to poor characterization of the promoter fragment being used or the influence of regulatory regions at the integration site causing ectopic expression. In contrast, the knock-in mouse strain we present here leverages the entire TRPM5 promoter in its native environment to drive Cre expression.
Importantly, Cre-mediated activation of the τGFP reporter transgene is irreversible. Therefore τGFP in TRPM5-IC/eR26-τGFP mice labels both cells that used to express TRPM5 as well as cells that acutely express TRPM5 at the time of analysis. We therefore generated and characterized an anti-TRPM5 antiserum to be able to distinguish between these two possibilities. τGFP cells were easily visualized in the different papillae of the tongue in these animals without signal amplification. Whole mount tongue epithelial preparations from TRPM5-IC/eR26-τGFP mice demonstrate that the τGFP cells are distributed in the VP, FoP, and FuP. In addition, τGFP-positive cells were also detected in the palatal epithelium. These data are consistent with the previous studies showing TRPM5 expression in all three tongue taste papillae and in the palate Chandrashekar et al. 2010) . A previous study using a TRPM5-EGFP transgenic mouse strain also demonstrated TRPM5 expression in the VP and FuP. In situ hybridization using TRPM5-or Cre-specific riboprobes and immunohistochemical analyses using the newly generated antiserum against TRPM5 on TRPM5-IC/ eR26-τGFP mouse VP demonstrate that τGFP faithfully reports acute TRPM5 expression in this tissue. Note that the anti-TRPM5 antiserum generated in this study did not show immunolabeling in the TRPM5 KO VP demonstrating its specificity. TRPM5-positive cells express different marker proteins such as Gα-gust, Gγ 13 , PLCβ2, and IP3R3 and are thus classified as type II taste cells (Perez et al. 2002) . The TRPM5-EGFP mouse VP immunostained with the type III taste cell marker SNAP-25 failed to show co-localization between Figure 7 . TRPM5-driven τGFP expression in the mouse trachea, bronchi, and urethra; 14-μm sections through the trachea, bronchi, and urethra of a TRPM5-IC/ eR26-τGFP mouse were stained with antisera against GFP (green) and TRPM5 (red). τGFP cells co-express TRPM5 in the trachea, bronchi (A and B) , and in the urethra (C). Scale bars (A, B) 20 µm, (C) 10 µm.
GFP and SNAP-25 corroborating earlier studies (Clapp et al. 2006) . Furthermore, immunohistochemistry (IHC) with different taste cell markers confirmed that τGFP cells do not express type I (NTPDase 2) or type III (AADC) taste cell markers in the TRPM5-IC/eR26-τGFP mice. Co-localization between τGFP and Skn-1a in the VP clearly demonstrates that τGFP is expressed in type II taste receptor cells. Taken together, our data show that Cre-mediated recombination in the taste papillae is restricted to TRPM5-expressing cells in the novel TRPM5-IC knock-in mouse strain and will thus allow their manipulation at a single-cell resolution in vivo.
Investigation of the τGFP cells in extra-gustatory tissues in the TRPM5-IC/eR26-τGFP mouse strain confirmed that TRPM5 expression is not restricted to taste tissue. Double-labeling analyses using antisera against GFP and TRPM5 show that τGFP faithfully reports acute TRPM5 expression in the gastric groove. The brush cells lining the gastric groove are considered to be chemosensory cells and express different taste cell markers such as Gα-gust and PLCβ2 (Eberle et al. 2013) . In addition to these taste signaling proteins, brush cells also express the G-protein coupled receptor subunit T1R3 that is involved in the detection of sweet and umami compounds (Hass et al. 2010 ). Other cell types in the alimentary tract such as enterocytes and enteroendocrine cells may also be chemosensory cells. Other than in the gastric groove, TRPM5 expression has also been reported in the corpus and antrum mucosa (Sothilingam et al. 2011) . Whether other cell types in these tissues express type II signaling molecules needs further investigation. We also detected TRPM5/τGFP cells in the intestinal tract. The presence of TRPM5/τGFP cells in the duodenum and colon is consistent with one previous study using the TRPM5-EGFP transgenic mouse strain (Bezencon et al. 2007) . Additional experiments showed the expression of different taste cell markers in the mouse gastrointestinal tract suggesting the presence of taste cells in the gut (Bezencon et al. 2007; Eberle et al. 2013b Eberle et al. , 2014 . τGFP cells were also easily detected in trachea, bronchi, and urethra in the TRPM5-IC/ eR26-τGFP animals, which should facilitate a more detailed characterization of these cells in the future.
In the OE of TRPM5-IC/eR26-τGFP mice, τGFP is expressed in two morphologically distinct populations of cell types as reported previously. Our results now demonstrate that two distinct GFPpositive cell types can also be detected in the SOM (OSNs and microvillar cells) as well as in the VNO (vomeronasal sensory neurons [VSNs] and non-sensory cells). TRPM5 is acutely expressed in the short population of τGFP cells in the OE of TRPM5-IC/eR26-τGFP mice. The location and morphology of these cells suggest that they are microvillar cells (Lin et al. 2008a ). However, a TRPM5-specific signal was not detected in the OSNs in adult animals using immunolabeling. This is in contrast to data obtained in the TRPM5-EGFP transgenic mouse OE labeled using a different TRPM5 antiserum than the one used here. Those data showed that TRPM5 is localized to the cilia layer of the OSNs (Lin et al. 2007 ). Note that the overall labeling pattern in the OE reported in that study is dramatically different from the one reported here with the new affinity purified anti-TRPM5 antiserum generated and characterized in this study. Possible explanations for the absence of TRPM5 signal in the τGFP-positive OSNs could be TRPM5 expression levels below the detection threshold or because TRPM5 was expressed during an earlier developmental stage in these cells. Considering the first hypothesis, the discrepancy in results could come from the fact that TRPM5 is expressed at low levels in the OSNs in the adult stage and that the IHC method used in the present study is not sensitive enough to detect the signal. Considering the second hypothesis a dynamic change in the TRPM5 mRNA expression profile has for example been observed in the lumbar dorsal root ganglia from embryonic day 12 to adulthood where TRPM5 is expressed at very low levels in the adult stage (Staaf et al. 2010) . Moreover, a recent study using in situ hybridization on adult OE reported TRPM5 mRNA signal only in the superficial layer, thereby supporting the absence of TRPM5 expression in the OSNs in adults (Yamaguchi et al. 2014) .
Additional experiments analyzing TRPM5 expression during development will be necessary to address these questions.
The new TRPM5 Cre knock-in strain can now be combined with different Cre-dependent reporter strains and viruses to study the molecular identity and the electrophysiological as well as pharmacological properties of TRPM5 cells in different tissues at a singlecell resolution. It will also suit additional experimental approaches requiring faithful expression such as genetic ablation and genetic calcium imaging. Furthermore, it can be used to knock out or activate individual genes specifically in these cells in a tissue-specific manner. The TRPM5-IC strain therefore represents a powerful new tool that will open new avenues and possibilities for the study of genetically labeled TRPM5 cells throughout the body. It is expected that it will contribute important insights into the role of TRPM5-expressing cells in various tissues as well as contribute to our understanding of the effects that this channel may have in different organs. 
